Kim Margolin
City Of Hope National Medical Center(US)Saint John's Health Center(US)Retina Partners(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Melanoma and MAPK Pathways, Brain Metastases and Treatment
Most-Cited Works
- → Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma(2015)2,105 cited
- → High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993(1999)2,025 cited
- → Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial(2015)1,554 cited
- → Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain(2018)1,297 cited
- → PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma(2016)1,234 cited
- → Sunitinib in Patients With Metastatic Renal Cell Carcinoma(2006)1,228 cited